|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:administered_by
|
gptkb:Loewe
gptkb:patches
hospital settings
injection
home care settings
|
|
gptkbp:available_on
|
gptkb:fentanyl_buccal_tablet
gptkb:fentanyl_citrate
gptkb:fentanyl_sublingual_spray
gptkb:fentanyl_transdermal_system
fentanyl nasal spray
|
|
gptkbp:developed_by
|
piperidine
|
|
gptkbp:has_half_life_of
|
3 to 12 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Fentanyl
|
|
gptkbp:is_associated_with
|
tolerance
withdrawal symptoms
dependence
overdose deaths
illicit drug trade
|
|
gptkbp:is_available_in
|
various formulations
tablet form
lozenge form
patch form
injection form
|
|
gptkbp:is_considered
|
highly potent
a dangerous drug when misused
a major contributor to the opioid epidemic
|
|
gptkbp:is_legally_controlled_in
|
many countries
|
|
gptkbp:is_often_accompanied_by
|
cocaine
heroin
|
|
gptkbp:is_often_prescribed_for
|
severe pain
|
|
gptkbp:is_often_used_in
|
recreational drug use
|
|
gptkbp:is_related_to
|
opioid crisis
|
|
gptkbp:is_subject_to
|
gptkb:regulations
abuse potential
|
|
gptkbp:is_used_for
|
acute pain
cancer pain
postoperative pain
|
|
gptkbp:is_used_in
|
gptkb:surgery
palliative care
intensive care units
emergency medicine
chronic pain management
anesthetic procedures
pain relief protocols
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:produced_by
|
pharmaceutical companies
|
|
gptkbp:scientific_classification
|
Schedule II controlled substance
|
|
gptkbp:side_effect
|
nausea
confusion
constipation
sedation
respiratory depression
|
|
gptkbp:strength
|
morphine
|
|
gptkbp:suitable_for
|
opioid-naive patients
|
|
gptkbp:used_for
|
pain management
|
|
gptkbp:was_first_synthesized_in
|
gptkb:1960
|
|
gptkbp:bfsParent
|
gptkb:Streams_of_Thought,_Vol._2
gptkb:Sub-Lingual_Tablet
gptkb:I_Wanna_Thank_Me
|
|
gptkbp:bfsLayer
|
5
|